How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

CO

NASDAQ:COCP
Get a brief AI stock analysisSaves ~ 15 minutes of your time

CO

Cocrystal Pharma IncNASDAQ COCP Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is COCP undervalued compared to its fair value?

The fair value of COCP stock is hidden USD. Relative to the market price of 2.35 USD Cocrystal Pharma Inc is hidden.

Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. The company is headquartered in Bothell, Washington and currently employs 13 full-time em...[More about valuation]

Cocrystal Pharma Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.024 $B

Price:

2.35 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.411

FINANCIALS

Cocrystal Pharma financial for reporting period

Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.006 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0042 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

Balance Sheet

0.033 B
0.031 B

Financial Position Analysis

Assets

0.033 B
Current Assets
0.032 B
Total non-current assets
0.0004 B

Total current liabilities
0.0019 B
Total non-current liabilities

Cash Flow Statement

-0.0027 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0027 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Cocrystal Pharma fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is COCP attractive for investment based on fundamental analysis?

COCP stock rating is hidden. Cocrystal Pharma is a hidden by Eyestock methodology.

Get COCP Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

COCP analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for COCP to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Cocrystal Pharma Inc competitors

LL

LLY

Eli Lilly and Co

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs ...

Discover

NO

NOVO B.CO

Novo Nordisk A/S

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. The firm is also engaged i...

Discover

JN

JNJ

Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. The company is headquartered in Ne...

Discover

Cocrystal Pharma Inc dividends

COCP dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About COCP stock

About the company Cocrystal Pharma Inc

Market cap $B

0.024

Dividend yield

Shares outstanding

8.143 B

Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. The company is headquartered in Bothell, Washington and currently employs 13 full-time employees. The company went IPO on 2018-03-12. The firm focuses on developing antiviral therapeutics that inhibit the essential viral replication function of RNA viruses causing acute and chronic viral diseases. The firm focuses on treating influenza virus, coronavirus, hepatitis C virus (HCV) and norovirus infections by discovering and developing drug candidates targeting the viral replication process. The firm uses computational methods to screen and design product candidates using cocrystal structural information. Its development pipeline includes CC-31244 and CC-42344. The Company’s CC-31244 is a pan-genotypic inhibitor of NS5B polymerase for the treatment of hepatitis C infection. The Company’s CC-42344 is a PB2 inhibitor for the treatment of influenza A infection. Its pipeline also includes CDI-45205 for the treatment of coronavirus. The company has also developed chemical libraries consisting of non-nucleoside inhibitors, metal-binding inhibitors, and drug-like fragments.

COCP profile

  • Ticker

    COCP

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    12 March 2018

  • Sector

    Healthсare

  • Industry

    Pharmaceuticals

  • Employees

    13

  • City

    Bothell

  • Address

    19805 N Creek Pkwy

  • Cusip

    19188J409